Delivery Order SPE2DB24D2205-SPE2DB25FECER

Award Date 5/12/25
Potential Completion Date 5/13/25
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to provide PRIORIX VIALS. The contract has a firm fixed price of $15,141.30 and a performance period through June 23, 2025. The contract is not set aside and is open to full and open competition. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of PRIORIX VIALS, a medical product, with a ceiling value of $3,772.49 and a performance period ending on May 1, 2025. The contract is a firm fixed-price delivery order, and it is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,957.37 firm-fixed-price contract is for the delivery of PRIORIX VIALS, with a period of performance through May 27, 2025. The contract is not set-aside and was competitively awarded. Amerisourcebergen Drug Corp is a significant supplier of pharmaceutical and medical products to the federal government, including the Defense Health...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,223.59, is for the delivery of PRIORIX VIALS, a medical product. The contract is a firm fixed-price delivery order with a period of performance through March 28, 2025. There is no set-aside designation for this award. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PRIORIX VIALS, a pharmaceutical product, with a ceiling value of $1,009.42 and a performance period through June 30, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PRIORIX VIALS, a pharmaceutical product, with a ceiling value of $21,197.82 and a completion date of May 15, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PRIORIX Vials, a medical product. The $16,804.66 firm fixed-price contract has an ultimate completion date of April 4, 2025. The award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PRIORIX Vials. The contract has a firm fixed price of $53,619.82 and a period of performance through May 14, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp is the prime contractor, and the contract is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of PRIORIX VIALS. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $15,141.30, and has an ultimate completion date of July 1, 2025. The contract is not set-aside and was awarded by the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisitions, and technical services to the U.S....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division, a major pharmaceutical distributor. The $2,536.50 contract is for the supply of PRIORIX VIALS, a vaccine product, with a period of performance through July 30, 2024. The contract is for firm fixed price delivery of the specified medical product. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FECER
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of PRIORIX VIALS. The contract has a firm fixed price of $15,141.30 and a period of performance through May 13, 2025. It is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order contract is part of the company's broader role as a critical vendor supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 8/17/25, 1:16 AM